Form 4: Corpay CFO Peter Walker Receives Equity Grant

Corpay's Chief Financial Officer, Peter Walker, was granted 1,772 shares of restricted common stock and 11,467 employee stock options on February 24, 2026.

Summary

• Peter Walker, Corpay's Chief Financial Officer and Director, acquired 1,772 shares of common stock and 11,467 employee stock options on February 24, 2026.
• The 1,772 shares of common stock are restricted stock, vesting ratably at 33% on February 24, 2027, 2028, and 2029.
• The 11,467 employee stock options have an exercise price of $338.77 and an expiration date of February 24, 2036.
• These options will vest ratably at 25% on February 24, 2027, 2028, 2029, and 2030.
• Both the restricted stock and options are subject to Mr. Walker's continued employment on the respective vesting dates.
• Following these transactions, Mr. Walker directly beneficially owns 6,696 shares of common stock and 11,467 employee stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value and retain key talent.

Positives

• The grant of restricted stock and stock options aligns the Chief Financial Officer's interests with long-term shareholder value creation.
• The multi-year vesting schedule incentivizes continued employment and performance over several years.
• The acquisition of additional equity by a key executive demonstrates confidence in the company's future.

Negatives

• No negative aspects are directly reported in this Form 4 filing, as it details an acquisition of equity by an insider.

Risks

• The vesting of both restricted stock and stock options is contingent upon the reporting person's continued employment with Corpay, Inc. on the applicable vesting dates.
• The value of the stock options is dependent on the future market price of Corpay's common stock exceeding the exercise price of $338.77.

Future Outlook

The vesting schedules for both the restricted stock and stock options extend several years into the future (up to 2030 for options and 2029 for restricted stock), indicating an expectation of the Chief Financial Officer's continued long-term commitment and contribution to Corpay, Inc.

Management Comments

• Peter Walker, Chief Financial Officer and Director, acquired 1,772 shares of restricted common stock and 11,467 employee stock options.
• The restricted stock will vest ratably (33%) on February 24, 2027, 2028, and 2029, subject to continued employment.
• The employee stock options, with an exercise price of $338.77, will vest ratably (25%) on February 24, 2027, 2028, 2029, and 2030, also subject to continued employment.

Industry Context

StockSavvy.ai notes that equity grants to key executives like the CFO are a standard practice across industries, particularly in the financial technology and business services sectors where Corpay operates. These grants are designed to align executive incentives with shareholder interests and promote long-term retention and performance, a common strategy for companies seeking to maintain stable leadership and drive sustained growth.

Comparison to Industry Standards

• Executive compensation packages in the financial technology sector frequently include a significant equity component, often comprising restricted stock units (RSUs) and stock options, similar to this grant.
• Companies like Fiserv (FISV) and Global Payments (GPN), direct competitors or peers in payment processing and business solutions, also utilize multi-year vesting schedules for executive equity awards to ensure long-term commitment and performance alignment.
• The vesting schedule of 3-4 years is typical for such grants, aiming to retain talent and incentivize sustained performance, aligning with best practices observed in large-cap technology and financial services firms.

Related Party Transactions

• The equity grant to Peter Walker, an officer and director, is a related party transaction, but it is a standard form of executive compensation and is disclosed as required by SEC regulations.

Stakeholder Impact

• Shareholders: The grant aligns the CFO's interests with long-term shareholder value.
• Employees: May signal stability in executive leadership.
• Management: Provides long-term incentives and retention for a key executive.

Next Steps

• Continued employment of Peter Walker with Corpay, Inc.
• Vesting of restricted stock on February 24, 2027, 2028, and 2029.
• Vesting of employee stock options on February 24, 2027, 2028, 2029, and 2030.
• Potential exercise of stock options by Peter Walker before the expiration date of February 24, 2036.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a key executive, which is a standard compensation practice and does not inherently suggest a significant change in the company's fundamental outlook or immediate share price trajectory. While it aligns executive incentives, it's not a catalyst for a 'buy' or 'sell' recommendation on its own. Investors should 'hold' and consider this information within the broader context of Corpay's financial performance and strategic initiatives.

Keywords

Corpay, CPAY, Peter Walker, Chief Financial Officer, CFO, Restricted Stock, Stock Options, Equity Grant, Insider Trading, SEC Form 4, Executive Compensation, Beneficial Ownership